Pharma's Almanac TV
Follow the Journey
Companies We've Met
AES Clean Technology
Avara Pharmaceutical Services
Federal Equipment Company
IPS-Integrated Project Services
TriRx Pharmaceutical Services
API - Small Molecule
Cell and Gene Therapy
Oral Solid Dosage
Biologics Pricing Report
Oral Solid Dose Market Report
Company A to Z
By The Numbers
43 Articles Available
Can't find what you're looking for? Try our
Q: What do you think is the greatest lesson learned from the COVID-19 pandemic, and what lasting impacts do you foresee over the next 5–10 years?
Q: Although there is no such thing as a truly “crisis-proof” organization, how are you working to mitigate risks for future crises like the COVID-19 pandemic?
Post COVID-19 Supply Chain
Q: How are you rethinking your supply chain and operational fitness in light of the COVID-19 pandemic?
Q: What steps is your company taking to address drug pricing issues?
Q: What is your perspective on how the pharma industry has responded to the COVID-19 pandemic? What lessons have been learned?
Q: What two or three drug molecules do you identify as having had the greatest impact on society? What about on the pharmaceutical industry?
Q: How would you characterize the current landscape of M&A activity in the pharmaceutical/biopharmaceutical industry?
Q: What technology do you foresee leading the industry over the coming decade, both in terms of real approvals and general impact?
Q: What developing technologies do you believe will have the greatest impact on the biopharma industry in 2020 and beyond?
Q: What breakthrough technologies have had a transformative effect on your business this year?
Q: How does your company manage to provide local services/support while still efficiently managing global compliance?
Q: What do you identify as the greatest advances that have been achieved in recent years with respect to harmonization of pharmaceutical regulations?
Q: What advances in manufacturing technology are most enabling the scale-up and commercialization of next-generation therapies?
Q: What truly novel therapies in the earliest stages of discovery and development do you believe will have a significant impact in the future?
Ethical Business Practices
Q: Given the ongoing evolution of the pharma industry today, how does your organization incorporate ethical concerns into your business practices?
Q: What do you believe the role of artificial intelligence and other advanced technologies will be in driving the development of the pharmaceutical industry over the next decade?
Q: What Innovative Technologies Had the Greatest Impact on your Company this Year? What Were the Impacts?
Q: Looking Forward, What New Technologies/Paradigms Do You Anticipate Having the Greatest Impact Next Year (Digitalization and Industry 4.0, Serialization, etc.)?
Q: What Role has M&A Played in your Company’s Growth?
Q: How do you Address Operational Excellence as an Institution?
Q: Looking forward, what technologies do you anticipate having the greatest impact in 2018?
Q: What do you see as being the most innovative technologies introduced in 2017? Why were they important? What impacts did they have?
Q: How important are international partnerships (with sponsor firms, service providers, engineering firms, equipment vendors, raw material suppliers, etc.) to your success?
Q: If You Could Have One Piece of Biologic Manufacturing Equipment Improved, What Would It Be and Why?